DISEASE INDICATIONS: Myelofibrosis
MANUFACTURER: Impact Biomedicines, Inc.
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Inrebic, known by its generic name Fedratinib, is a medication used to treat certain rare bone marrow disorders, specifically myelofibrosis.
